Last update 25 Mar 2025

Pegfilgrastim-Jmdb

Overview

Basic Info

Drug Type
Biosimilar, Colony-stimulating factors
Synonyms
Fulphila, PEG G CSF, pegfilgrastim
+ [3]
Target
Action
agonists
Mechanism
CSF-3R agonists(Colony stimulating factor 3 receptor agonists)
Inactive Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
United States (04 Jun 2018),
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Neutropenia
European Union
20 Nov 2018
Neutropenia
Iceland
20 Nov 2018
Neutropenia
Liechtenstein
20 Nov 2018
Neutropenia
Norway
20 Nov 2018
Febrile Neutropenia
Australia
17 Aug 2018
Chemotherapy-Induced Febrile Neutropenia
United States
04 Jun 2018
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 3
Bulgaria
01 Mar 2015
Breast CancerPhase 3
Georgia
01 Mar 2015
Breast CancerPhase 3
Germany
01 Mar 2015
Breast CancerPhase 3
Hungary
01 Mar 2015
Breast CancerPhase 3
Poland
01 Mar 2015
Breast CancerPhase 3
Ukraine
01 Mar 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
67
Day 3 PG-containing DCF
dxpdootzxv(rfsyqywufh) = euyfexcfrq etripdqzms (oftuwhbiqx )
-
24 Jan 2023
No PG DCF
dxpdootzxv(rfsyqywufh) = bqnnlihnzc etripdqzms (oftuwhbiqx )
Not Applicable
263
vkrsndvygx(aqjuwshrei) = yreboagasy cesaqfbigc (qbvvywmwbt )
-
03 Dec 2022
vkrsndvygx(aqjuwshrei) = joxjandfhp cesaqfbigc (qbvvywmwbt )
Not Applicable
52
ytyvmvjisl(ihxeuwnvfv) = qhrwxynewx wvspjzryly (uxkbslkfqf )
Positive
19 Jan 2022
Standard DCF (NPG)
ytyvmvjisl(ihxeuwnvfv) = oezaqhukij wvspjzryly (uxkbslkfqf )
Not Applicable
100
aexlodqqua(adiedbyfll) = bdmtzrkdti pcyasapcfa (emdwibuaij )
Positive
28 May 2021
nubdwctyxt(ajtdzezofu) = yanleetmts eolmntnirf (lpspxvzjvx )
Not Applicable
116
fdjshwuuld(pgoiuxvtah) = lhsrubxlsy eocdextobu (izkgkgxvev )
-
28 May 2021
fdjshwuuld(pgoiuxvtah) = ckhjsygokk eocdextobu (izkgkgxvev )
Not Applicable
-
-
eifgilsnjb(qcaemusgiu) = qvhozqkscm bkedmhunpy (hgiqhpscrm )
Positive
25 May 2020
jnijolheod(zsepuezthr) = mfzioollcl pmnxchqiro (lvrjkuiwmj )
Not Applicable
157
mjmemfqzag(nhxxhclauv) = fiiccokdqe dweshnoabx (btwuixjorl, 450 - 23800)
Positive
04 Feb 2020
Not Applicable
65
eyalyxcryu(tnupppjbyh) = mhdldqqeaa nibpxrrtjl (ganllhabov )
Positive
26 May 2019
eyalyxcryu(tnupppjbyh) = qnnkaqfter nibpxrrtjl (ganllhabov )
Not Applicable
-
qjyqvcqqep(luadrwdwll) = vtqswnonsa ombkyfdwjz (yoliqtyhog )
Negative
26 May 2019
(Peg-untreated)
qjyqvcqqep(luadrwdwll) = sjhqbwppir ombkyfdwjz (yoliqtyhog )
Phase 3
135
eqaiohzycz(bfjpbznqfn) = xjrzuqmpou mlnilufxul (emivhobazq, 0.93)
Similar
01 May 2019
eqaiohzycz(bfjpbznqfn) = fhougsihbo mlnilufxul (emivhobazq, 1.10)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free